MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.mce.2026.112855

Медицинская библиотека · Molecular and cellular endocrinology · 2026

Female-specific metabolic genetic liability reveals a separable metabolic dimension of polycystic ovary syndrome.

Wang Suijian, Wang Kui

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Polycystic ovary syndrome (PCOS) frequently co-occurs with obesity, insulin resistance, dyslipidaemia and metabolic syndrome (MetS). However, whether this metabolic burden represents secondary comorbidity or an intrinsic component of PCOS genetic architecture remains unclear.

METHODS

We used genomic structural equation modelling to construct female- and male-specific hierarchical MetS latent factors from six sex-stratified cardiometabolic GWAS, including BMI, waist circumference, triglycerides, HDL cholesterol, type 2 diabetes and fasting glucose. Sex-specific MetS genetic architecture was evaluated using latent factor GWAS, sex-difference testing, MiXeR, MAGMA and GSA-MiXeR. To assess the relationship between MetS liability and PCOS, we performed CPASSOC, conjunctional FDR, Bayesian colocalization, GWAS-by-subtraction and GenomicSEM-based mediation analysis.

RESULTS

Female and male MetS factors shared a highly overlapping polygenic backbone, but their genetic correlation was significantly below unity. Among comparable lead variants, 9.1% showed sex-dimorphic effects, and MiXeR estimated an approximately fourfold larger female-specific causal component than the male-specific component. Cross-trait analysis identified 45 candidate pleiotropic loci linking PCOS with the female MetS factor, 34 conjFDR-supported shared loci and 10 loci with strong Bayesian colocalization evidence, including FTO, ERBB3, FGFR1, KLF16 and TEX41. GWAS-by-subtraction showed that 16.7% of PCOS genetic variance was shared with female MetS, whereas 83.3% remained MetS-independent and retained stronger reproductive-endocrine features. Variant-level mediation further showed that MetS-mediated effects were locus-specific rather than a global amplifier of PCOS risk.

CONCLUSIONS

This study redefines the metabolic comorbidity of PCOS as a separable, female-biased genetic dimension embedded within, but distinct from, the predominant reproductive-endocrine genetic architecture of PCOS. These findings provide a genetic framework for resolving reproductive-metabolic heterogeneity in PCOS and may inform future risk stratification and precision management of metabolic complications in women with PCOS.

Для цитирования: Wang Suijian, Wang Kui. Female-specific metabolic genetic liability reveals a separable metabolic dimension of polycystic ovary syndrome.. Molecular and cellular endocrinology. 2026. DOI: 10.1016/j.mce.2026.112855.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.